Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etaracizumab in plaque psoriasis
NCT00192517Phase 2Completed
- Sponsor
- MedImmune
- Start
- Dec 2003
- Primary completion
- Aug 2004
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of etaracizumab in plaque psoriasis, sponsored by MedImmune. Started Dec 2003; status: completed.
02
Drugs
etaracizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00192517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192517.